|
This is an index of adverse event reports related to Emtriva (Emtricitabine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (22)
Cases resulting in a serious event (22)
Cases resulting in death (6)
Cases resulting in hospitalization (15)
Cases resulting in other serious reactions (8)
Adverse event in male receiving Emtriva (Emtricitabine)
Reported by a physician from Japan on 2007-10-22
Patient: male
Adverse reactions / side effects: Immune Reconstitution Syndrome, Cytomegalovirus Chorioretinitis, Bone Marrow Failure
Suspect drug(s):
Emtriva
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-01-01
Viread
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-01-01
Truvada
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2005-12-10
End date: 2006-01-01
Other drugs received by patient: Efavirenz
Adverse event in 43 year old male receiving Emtriva (Emtricitabine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-16
Patient: 43 year old male
Adverse reactions / side effects: Immune Reconstitution Syndrome, Cytomegalovirus Chorioretinitis, Bone Marrow Failure
Adverse event resulted in: hospitalization
Suspect drug(s):
Stocrin Caps
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2005-12-10
Baktar
Administration route: Oral
Indication: Pneumocystis Jiroveci Pneumonia
Start date: 2006-01-01
Viread
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-01-01
Emtriva
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-01-01
Valixa
Administration route: Oral
Indication: Cytomegalovirus Chorioretinitis
Start date: 2006-01-17
Truvada
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2005-12-10
End date: 2006-01-01
Rabeprazole Sodium
Administration route: Oral
Indication: Adverse Drug Reaction
Start date: 2005-12-01
Gasmotin
Administration route: Oral
Indication: Adverse Drug Reaction
Start date: 2006-01-01
Adverse event in 47 year old male receiving Emtriva (Emtricitabine)
Reported by a physician from United States on 2007-07-12
Patient: 47 year old male, weighing 73.9 kg (162.7 pounds)
Adverse reactions / side effects: Dermatitis Allergic, Pancreatitis Acute, Hiatus Hernia, Urine Output Decreased, Hepatic Steatosis, Haemoglobin Decreased, Portal Hypertensive Gastropathy, Platelet Count Decreased, Blood Creatinine Increased, Rebound Effect, Splenomegaly
Adverse event resulted in: hospitalization
Suspect drug(s):
MK-0518
Dosage: 200 mg/bid/po; 200 mg/bid/po; 400 mg/bid/po;
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
MK-0518
Dosage: 200 mg/bid/po; 200 mg/bid/po; 400 mg/bid/po;
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-05-29
MK-0518
Dosage: 200 mg/bid/po; 200 mg/bid/po; 400 mg/bid/po;
Administration route: Oral
Indication: HIV Infection
Start date: 2006-05-30
End date: 2006-12-18
Placebo
Dosage: po; po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Placebo
Dosage: po; po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-05-29
Truvada
Dosage: 1 tablet/daily/po; 1 tablet/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Truvada
Dosage: 1 tablet/daily/po; 1 tablet/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-03-09
Norvir
Dosage: 200 mg/bid/po; 100 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-01
End date: 2005-05-04
Norvir
Dosage: 200 mg/bid/po; 100 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-12-18
Zidovudine
Dosage: 300 mg/bid/po; 300 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Zidovudine
Dosage: 300 mg/bid/po; 300 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-12-18
Invirase
Dosage: 2000 mg/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Crixivan
Dosage: 800 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-12-18
Emtriva
Dosage: 200 mg/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2006-03-10
End date: 2006-12-18
Vicks INH
Dosage: 4 puff/daily/inh
Indication: Sinus Congestion
Start date: 2007-01-10
End date: 2007-01-12
Other drugs received by patient: Feldene; Feldene; Feldene; Lomotil; Lopid; Neurontin; Nicoderm; Oxandrin; Oxycontin; Oxycontin; Oxycontin; Phenergan (Promethazine Hydrochl; Protonix; Roxicodone; Senokot; Zantac 150; [therapy Unspecified]; Acetaminophen (+) Phenylephrine; Dextrose 5% and Sodium Chloride 0.45% IN Plastic Container; Docusate Sodium; Fenofibrate; Hydromorphone Hydrochloride; Magnesium Sulfate; Pentamidine Isethionate; Prochlorperazine; Sodium Chloride
Adverse event in male receiving Emtriva (Emtricitabine)
Reported by a physician from Mexico on 2007-07-10
Patient: male
Adverse reactions / side effects: Multi-Organ Failure, Opportunistic Infection
Adverse event resulted in: death
Suspect drug(s):
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2007-03-05
End date: 2007-03-10
Emtriva
Administration route: Oral
Indication: HIV Infection
Start date: 2007-03-05
End date: 2007-03-10
Other drugs received by patient: Efavirenz; Fluconazole
Adverse event in 47 year old male receiving Emtriva (Emtricitabine)
Reported by a physician from United States on 2007-06-18
Patient: 47 year old male, weighing 73.9 kg (162.7 pounds)
Adverse reactions / side effects: Pancreatitis Acute, Nasopharyngitis, Skin Burning Sensation, Hyperhidrosis, Rash Pruritic, Laboratory Test Abnormal, Skin Warm, Rebound Effect, Splenomegaly, Facial Wasting, Blood Alkaline Phosphatase Increased, Hiatus Hernia, Nausea, Urine Output Decreased, Alanine Aminotransferase Increased, Drug Hypersensitivity, Condition Aggravated, Hepatic Steatosis, Portal Hypertensive Gastropathy, Haemoglobin Decreased, Diarrhoea, Aspartate Aminotransferase Increased, Platelet Count Decreased, Gait Disturbance, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Suspect drug(s):
MK-0518
Dosage: see image
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
MK-0518
Dosage: see image
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-05-29
MK-0518
Dosage: see image
Administration route: Oral
Indication: HIV Infection
Start date: 2006-05-30
End date: 2006-12-18
Placebo
Dosage: unk/unk/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Placebo
Dosage: unk/unk/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-05-29
Truvada
Dosage: 1 tablet/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Truvada
Dosage: 1 tablet/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-03-09
Norvir
Dosage: see image
Administration route: Oral
Indication: HIV Infection
Start date: 2000-03-01
End date: 2005-05-04
Norvir
Dosage: see image
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-12-18
Zidovudine
Dosage: 300 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Zidovudine
Dosage: 300 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-12-18
Invirase
Dosage: 2000 mg/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-05-04
End date: 2005-05-04
Crixivan
Dosage: 800 mg/bid/po
Administration route: Oral
Indication: HIV Infection
Start date: 2005-08-21
End date: 2006-12-18
Emtriva
Dosage: 200 mg/daily/po
Administration route: Oral
Indication: HIV Infection
Start date: 2006-03-10
End date: 2006-12-18
Vicks INH
Dosage: 4 puff/daily/inh
Indication: Sinus Congestion
Start date: 2007-01-10
End date: 2007-01-12
Other drugs received by patient: Therapy Unspecified; Feldene; Feldene; Lomotil; Lopid; Neurontin; Nicoderm; Oxandrin; Oxycontin; Oxycontin; Oxycontin; Phenergan (Promethazine Hydrochl; Protonix; Roxicodone; Senokot; Zantac; [therapy Unspecified]; Dextrose 5% and Sodium Chloride 0.45% IN Plastic Container; Docusate Sodium; Fenofibrate; Hydromorphone Hydrochloride; Magnesium Sulfate; Pentamidine Isethionate; Prochlorperazine; Sodium Chloride
Adverse event in 41 year old male receiving Emtriva (Emtricitabine)
Reported by a health professional (non-physician/pharmacist) from Spain on 2007-06-05
Patient: 41 year old male
Adverse reactions / side effects: Gamma-Glutamyltransferase Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
Suspect drug(s):
Emtriva
Administration route: Oral
Start date: 2006-09-20
End date: 2007-03-01
Viread
Administration route: Oral
Start date: 2006-09-20
End date: 2007-03-01
Viramune
Administration route: Oral
Start date: 1999-10-20
End date: 2007-03-01
Adverse event in male receiving Emtriva (Emtricitabine)
Reported by a physician from Mexico on 2007-04-06
Patient: male, weighing 54.0 kg (118.8 pounds)
Adverse reactions / side effects: Pancreatitis Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Emtriva
Administration route: Oral
Indication: HIV Infection
Start date: 2007-03-10
End date: 2007-03-12
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2007-03-10
End date: 2007-03-12
Other drugs received by patient: Efavirenz
Adverse event in 19 year old female receiving Emtriva (Emtricitabine)
Reported by a individual with unspecified qualification from United States on 2007-04-03
Patient: 19 year old female
Adverse reactions / side effects: PRE-Eclampsia, Pregnancy
Suspect drug(s):
Emtriva
Administration route: Oral
Indication: HIV Infection
End date: 2005-07-27
Viread
Administration route: Oral
Indication: HIV Infection
End date: 2005-07-27
Other drugs received by patient: Retrovir; Sustiva; Trizivir
Adverse event in male receiving Emtriva (Emtricitabine)
Reported by a physician from Mexico on 2007-04-03
Patient: male
Adverse reactions / side effects: Multi-Organ Failure, Opportunistic Infection
Adverse event resulted in: death
Suspect drug(s):
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2007-03-05
End date: 2007-03-10
Emtriva
Administration route: Oral
Indication: HIV Infection
Start date: 2007-03-05
End date: 2007-03-10
Other drugs received by patient: Efavirenz; Fluconazole
Adverse event in male receiving Emtriva (Emtricitabine)
Reported by a physician from United States on 2007-03-15
Patient: male
Adverse reactions / side effects: Multi-Organ Failure, Hepatitis B
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2007-02-01
End date: 2007-02-09
Viread
Administration route: Oral
Start date: 2007-01-17
End date: 2007-01-30
Emtriva
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-05
End date: 2007-02-09
Prezista
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-05
End date: 2007-02-09
Other drugs received by patient: Videx CC; Norvir
Adverse event in 48 year old male receiving Emtriva (Emtricitabine)
Reported by a health professional (non-physician/pharmacist) from Spain on 2007-03-05
Patient: 48 year old male, weighing 79.0 kg (173.8 pounds)
Adverse reactions / side effects: Hyponatraemia, Metabolic Disorder, Asthenia, Hypokalaemia, Arrhythmia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Sustiva
Indication: HIV Infection
Start date: 2006-11-28
Videx
Indication: HIV Infection
Start date: 2006-11-28
Emtriva
Adverse event in 58 year old male receiving Emtriva (Emtricitabine)
Reported by a physician from United States on 2007-03-01
Patient: 58 year old male
Adverse reactions / side effects: Multi-Organ Failure, Hepatitis B
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2007-02-01
Viread
Administration route: Oral
Start date: 2007-01-17
End date: 2007-01-30
Emtriva
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-05
Prezista
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-05
Other drugs received by patient: Videx CC; Norvir
Adverse event in female receiving Emtriva (Emtricitabine)
Reported by a individual with unspecified qualification from United States on 2007-02-14
Patient: female
Adverse reactions / side effects: NO Adverse Effect
Suspect drug(s):
Emtriva
End date: 2005-07-27
Viread
End date: 2005-07-27
Other drugs received by patient: Retrovir; Sustiva
Adverse event in 19 year old female receiving Emtriva (Emtricitabine)
Reported by a individual with unspecified qualification from United States on 2007-02-14
Patient: 19 year old female
Adverse reactions / side effects: PRE-Eclampsia, Pregnancy
Suspect drug(s):
Emtriva
Administration route: Oral
Indication: HIV Infection
End date: 2005-07-27
Viread
Administration route: Oral
Indication: HIV Infection
End date: 2005-07-27
Other drugs received by patient: Retrovir; Sustiva
Adverse event in 48 year old male receiving Emtriva (Emtricitabine)
Reported by a health professional (non-physician/pharmacist) from Spain on 2007-02-06
Patient: 48 year old male, weighing 79.0 kg (173.8 pounds)
Adverse reactions / side effects: Hyponatraemia, Metabolic Disorder, Asthenia, Hypokalaemia, Arrhythmia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Sustiva
Indication: HIV Infection
Start date: 2006-11-28
Videx
Indication: HIV Infection
Start date: 2006-11-28
Emtriva
Adverse event in 53 year old male receiving Emtriva (Emtricitabine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-30
Patient: 53 year old male
Adverse reactions / side effects: Myocardial Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Sustiva
Administration route: Oral
Start date: 2005-04-01
End date: 2006-11-21
Kaletra
Administration route: Oral
Start date: 2005-04-01
End date: 2006-11-21
Emtriva
Administration route: Oral
Start date: 2005-04-01
End date: 2006-11-21
Other drugs received by patient: Aspegic 1000; Triatec; Plavix; Sectral
Adverse event in 47 year old male receiving Emtriva (Emtricitabine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-22
Patient: 47 year old male, weighing 77.0 kg (169.4 pounds)
Adverse reactions / side effects: Photosensitivity Reaction, Pruritus, Haemoglobinaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2003-01-01
Emtriva
Administration route: Oral
Start date: 2006-01-01
Baclofen
Administration route: Oral
Viread
Administration route: Oral
Start date: 2003-01-01
Norvir
Administration route: Oral
Start date: 2003-01-01
Zelitrex
Administration route: Oral
Start date: 2006-02-01
Other drugs received by patient: Mixtard Human 70 / 30; Atarax; Bactrim
Adverse event in 53 year old male receiving Emtriva (Emtricitabine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-22
Patient: 53 year old male
Adverse reactions / side effects: Myocardial Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Sustiva
Administration route: Oral
Start date: 2005-04-01
End date: 2006-11-21
Kaletra
Administration route: Oral
Start date: 2005-04-01
End date: 2006-11-21
Emtriva
Administration route: Oral
Start date: 2005-04-01
End date: 2006-11-21
Other drugs received by patient: Aspegic 1000; Triatec; Plavix; Sectral
Adverse event in 44 year old male receiving Emtriva (Emtricitabine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-19
Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)
Adverse reactions / side effects: Hypercholesterolaemia, Diarrhoea, Hypertriglyceridaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Viread
Administration route: Oral
Start date: 2004-02-06
End date: 2005-05-13
Emtriva
Truvada
Viramune
Administration route: Oral
Start date: 2004-02-06
End date: 2005-05-13
Norvir
Administration route: Oral
Start date: 2005-05-13
Ziagen
Administration route: Oral
Start date: 2004-02-06
Kaletra
Administration route: Oral
Start date: 2005-05-13
End date: 2005-11-02
Telzir
Administration route: Oral
Start date: 2005-05-13
End date: 2006-12-20
Other drugs received by patient: Videx
Adverse event in 47 year old male receiving Emtriva (Emtricitabine)
Reported by a consumer/non-health professional from France on 2007-01-18
Patient: 47 year old male, weighing 77.0 kg (169.4 pounds)
Adverse reactions / side effects: Macrocytosis, Photosensitivity Reaction, Skin Exfoliation, Alanine Aminotransferase Increased, Haemoglobinaemia, Blister, Prurigo
Adverse event resulted in: hospitalization
Suspect drug(s):
Zelitrex
Dosage: 500mg twice per day
Administration route: Oral
Start date: 2006-02-01
Norvir
Dosage: 100mg per day
Administration route: Oral
Start date: 2003-01-01
Viread
Dosage: 1unit per day
Administration route: Oral
Start date: 2003-01-01
Reyataz
Dosage: 150mg per day
Administration route: Oral
Start date: 2003-01-01
Emtriva
Administration route: Oral
Start date: 2006-01-01
Baclofene
Dosage: 10mg per day
Administration route: Oral
Other drugs received by patient: Mixtard Human 70 / 30; Atarax; Bactrim
Adverse event in 53 year old male receiving Emtriva (Emtricitabine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-18
Patient: 53 year old male
Adverse reactions / side effects: Myocardial Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Emtriva
Administration route: Oral
Start date: 2005-04-01
End date: 2006-11-21
Sustiva
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-01
End date: 2006-11-21
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-01
Other drugs received by patient: Aspegic 1000; Triatec; Plavix; Sectral
Adverse event in 47 year old male receiving Emtriva (Emtricitabine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-18
Patient: 47 year old male, weighing 77.0 kg (169.4 pounds)
Adverse reactions / side effects: Photosensitivity Reaction, Pruritus, Haemoglobinaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Emtriva
Administration route: Oral
Start date: 2006-01-01
Viread
Administration route: Oral
Start date: 2003-01-01
Zelitrex
Administration route: Oral
Start date: 2006-02-01
Norvir
Administration route: Oral
Start date: 2003-01-01
Reyataz
Start date: 2003-01-01
Baclofene Irex
Administration route: Oral
Other drugs received by patient: Mixtard Human 70 / 30; Atatrax; Bactrim
|
